People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Carogen Corporaton | — | Biotechnology | Seed | $2.1M | $92.4M | 2016 |
| Bioxiness Pharmaceuticals, Inc. | — | Pharmaceuticals | Pre-Seed | $805K | $23.7M | 2016 |
Susan Froshauer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Susan Froshauer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frank Marco | 1 | 2 |
| Matthew Kerby | 1 | 1 |
| Constance McKee | 1 | 1 |
| Mansour Bassiri | 1 | 1 |
| Bijan Almassian | 1 | 1 |
| Valerian Nakaar | 1 | 1 |
| Reza Ilkhani | 1 | 1 |
| Clinton Severson | 1 | 1 |
| Clint H. Severson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.